 Dornsife says that listening to patients could help scientists understand what drugs will be effective. For example, many patients aren't eligible to participate because they have a secondary condition like heart disease. It makes sense to a certain degree because as a researcher, you want the cream of the crop because you want your drug to work, right? And you want to get approval and get to market. But unfortunately, that's not how the real world works.